SHCNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Sotera Health Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$17.64−0.25 (-1.40%)
Close on Oct 19, 2026
- Market cap
- $5.08B
- P/E (TTM)
- 30.9
- Dividend yield
- –
Sotera Health Co revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sterigenics | $788.96M | $772.23M | $755.78M | $736.80M | $719.53M | $701.04M | $697.85M | $690.62M | $683.39M | $673.63M | $667.13M | $656.60M | 64.9% | +9.7% |
| Nelson Labs | $223.42M | $219.84M | $220.22M | $219.00M | $221.92M | $223.84M | $229.23M | $233.46M | $229.61M | $227.33M | $221.70M | $219.32M | 18.4% | +0.7% |
| Nordion | $203.79M | $197.07M | $187.62M | $194.58M | $183.09M | $181.91M | $173.36M | $196.40M | $185.18M | $175.92M | $160.46M | $114.71M | 16.8% | +11.3% |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sterigenics | $431.68M | $421.30M | $412.89M | $402.49M | $391.32M | $380.36M | $378.17M | – | – | – | – | – | +10.3% |
| Nordion | $118.37M | $113.87M | $107.58M | $114.23M | $107.91M | $107.86M | $101.22M | – | – | – | – | – | +9.7% |
| Nelson Labs | $71.57M | $71.45M | $73.33M | $72.98M | $72.63M | $70.26M | $69.18M | – | – | – | – | – | -1.5% |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $1.03B | $1.01B | $995.76M | $975.51M | $958.77M | $939.28M | $941.82M | $940.95M | $929.28M | $917.57M | $905.60M | $888.06M | 85.1% | +7.9% |
| Product | $181.67M | $175.72M | $167.86M | $174.87M | $165.77M | $167.51M | $158.62M | $179.53M | $168.91M | $159.31M | $143.69M | $102.58M | 14.9% | +9.6% |
By region
From the segment and revenue-disaggregation notes of Sotera Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.